5073 POSTER Bevacizumab (Bev) Combined With Paclitaxel (Pac) as First-line Therapy for Metastatic Triple-negative Breast Cancer (TNBC) -Analysis of 147 Patients (pts) Treated in Routine Oncology Practice in Germany

✍ Scribed by Schneeweiss, A.; Foerster, F.; Hollburg, W.; Tesch, H.; Klare, P.; Wuelfing, P.; Distelrath, A.; Schumacher, C.; Steffens, C.C.; Schmidt, M.

• Book ID: 122910182
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 41 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71515-5